Fenton Mary Kay Insider Trading Activity (CGEM)

Summary

Updated Jul 16, 2026

Fenton Mary Kay has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $60K.

Profile

Mary Kay Fenton serves as Chief Financial Officer of Cullinan Therapeutics, Inc. (CGEM), as reflected in the SEC filing with CIK 0001378589 dated 2026-01-05. The filing shows no reported purchases or sales by her, indicating standard disclosure for a senior financial executive in that period. Based on the SEC context, she provides financial leadership for Cullinan Therapeutics as it advances its clinical-stage oncology and autoimmune programs.

Role	Insider
Notability	45/100

Board memberships

Cullinan Therapeutics, Inc.

Awards & honors

Serves as Chief Financial Officer for Cullinan Therapeutics, overseeing financial operations and reporting
Leads financial strategy and regulatory compliance in support of the company's clinical-stage programs

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-02	CGEM	Cullinan Therapeutics, Inc.	A — Grant or award	1.5K	$8.60	$13K
2026-02-23	CGEM	Cullinan Therapeutics, Inc.	S — Open-market sale	4.4K	$13.62	$60K
2026-02-19	CGEM	Cullinan Therapeutics, Inc.	A — Grant or award	68.8K	$0.00
2026-01-05	CGEM	Cullinan Therapeutics, Inc.	A — Grant or award	27	$6.49	$175

Frequently Asked Questions

Who is Fenton Mary Kay?

How many SEC Form 4 filings has Fenton Mary Kay submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Fenton Mary Kay been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($60K) across all tracked filings.

Where can I see all of Fenton Mary Kay's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Fenton Mary Kay — SEC Form 4 Insider Trading Activity